Overview

Clinical Trial to Evaluate the Efficacy and Safety of CKD-386

Status:
Completed
Trial end date:
2021-06-18
Target enrollment:
0
Participant gender:
All
Summary
Clinical Trial to Evaluate the Efficacy and Safety of CKD-386
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical
Treatments:
Antihypertensive Agents
Hypolipidemic Agents
Criteria
Inclusion Criteria:

1. Subjects are diagnosed with Dyslipidemia Patients with Hypertension or are being
administered anti-hypertension and anti-hypertension drugs after diagnosis.

2. Subjects who agreed to participate in this clinical trial voluntarily.

Exclusion Criteria:

1. Subjects who were satisfied specific blood pressure levels that measured at screening
period.

2. Subjects who were satisfied specific lipid levels that measured at screening period.

3. Subjects who cannot participate in a clinical trial based on the PI's judgment.